CNCE

Concert Pharmaceuticals, Inc. News Headlines

$14.39
*  
1.26
8.05%
Get CNCE Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading CNCE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
InsiderInsights.com Daily Round Up 11/20/14: NES, OPK, OKS, PAH
11/24/2014 3:04:00 PM - Seeking Alpha


Flamel Technologies: A Turnaround Story With Lots Of Upside
11/21/2014 1:05:00 PM - Seeking Alpha


Concert's First Drug: Not So Great
4/29/2014 1:07:00 PM - Seeking Alpha


Concert Pharmaceuticals Quiet Period Expiration Could Be A Well-Orchestrated Long Opportunity For Investors
3/3/2014 10:43:00 AM - Seeking Alpha


Auspex Is A Compelling Short Idea
2/19/2014 10:14:00 AM - Seeking Alpha


Health IPOs Down 1% And Housing IPOs Trade Up After Heavy Discount
2/14/2014 12:22:00 PM - Seeking Alpha


IPO Preview: Concert Pharmaceuticals
2/13/2014 1:00:00 AM - Seeking Alpha


Concert Pharmaceuticals IPO Sounds Good
2/12/2014 3:54:00 PM - Seeking Alpha


9 U.S. IPOs Planned For The Week Of Feb. 10
2/11/2014 7:32:00 AM - Seeking Alpha


U.S. IPO Recap: Revance Jumps 68% In 10 IPO Week
2/11/2014 7:27:00 AM - Seeking Alpha


Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha